Thursday, June 17, 2021


Interested in Pharma? Get latest global pharma industry updates right here. Know about new development from pharma giants like J&J, Abbott, Pfizer, Sanofi, Roche, Sun Pharma, Cipla, Glenmark and other multinational pharma company. The news is aggregated from multiple leading and reliable global sources so that you can trust what you read blind folded.


J&J exec urges industry to start thinking ‘cure’ in cancer

Amid COVID-19 lockdowns, routine cancer screenings were put on the back burner. While that may be short-term harm from the pandemic, the crisis also...

Regeneron’s COVID-19 antibodies breach a new frontier by cutting deaths in some hospitalized patients

Antibody treatments have shown little success in helping COVID-19 patients with severe disease. But a large study of hospitalized patients reveals that Regeneron’s antibody...

Bharat Biotech supplies Covaxin to 16 states

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.Company's...

US’ Centers for Disease Control calls coronavirus Delta variant a ‘variant of concern’

The US Centers for Disease Control and Prevention now called the Delta variant of the novel coronavirus, also known as B.1.617.2, a "variant of...

Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen

Novartis and Amgen were the first onto the CGRP scene with migraine drug Aimovig, but tensions ensued shortly into the drug's launch as both...

UK approves Pfizer/BioNTech Covid shot for 12 to 15year-olds

Britain's medicines regulator said on Friday it had approved the Covid-19 vaccine developed by Pfizer and BioNTech for use on 12- to 15-year-olds, following similar clearances in the U.S. and the E.U.

Vax policy ‘arbitrary and irrational’, show roadmap till Dec 31: SC to govt

In what could fuel criticism of the Centre's Covid-19 vaccination policy, the Supreme Court on Wednesday termed non-extension of free vaccination to the 18-44 age group as "prima facie arbitrary and irrational" and asked why budgetary allocation of Rs 35,000 crore for the vaccine could not be used to inoculate this group free of cost.

Sanofi looks to take Mylan to court, again, over EpiPen antitrust allegations

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its more "consumer-friendly" alternative Auvi-Q. Now, it's appealing to the Tenth Circuit to make its case heard.

Pfizer, Moderna vaccines may soon be available in India

The Drugs Controller General of India (DCGI) has given a green signal to foreign vaccines to be approved in India without specific clinical trials...

DRDO issues directions for use of anti-covid drug 2-DG

The Defence Research and Development Organisation (DRDO) on Tuesday issued directions on how to use the new drug called 2-DG for Covid patients.

Pharma drug naming experts applaud WHO’s choice of Greek alphabet for COVID-19 variants

Pharma drug naming experts applaud WHO's choice of Greek alphabet for COVID-19 variants

On a roll, Moderna taps Thermo Fisher for fill-finish duties and Lonza for booster shot manufacturing

The globe has come to depend on Moderna’s COVID-19 vaccine, sending the biotech racing to expand its mRNA manufacturing capacity. In the next step of its effort to meet lofty supply expectations, Moderna is leveraging its relationships with two CDMO powerhouses to help.

MPs tell Boris Johnson: you have a duty to help vaccinate the world

MP's advice to UK's prime minister Mr. Boris Johnson on vaccinating the world

Jabs for all by Dec, says govt as India’s SC quizzes it on vax policy

New Delhi: The Centre on Monday told the Supreme Court that it expects the country’s entire population above 18 years to be vaccinated against...

Mumbai startup develops disinfection system to make N95 masks, PPE and medical gears reusable

The disinfection system, called Vajra Kavach, will help in significantly cutting the cost of combating the pandemic Mumbai-based startup Indra Water has developed a disinfection...

87% of last week’s deceased were unvaccinated 45 +

Information about last week deceased unvaccinated covid affected population


The pharma company in India was estimated at US$33 billion out of 2017 and generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. Indian pharma industry is right now estimated at $41 bn. The pharma industry is expected to reach $65 bn by 2024 and $120 bn by 2030.

Key point:

  • Indian pharma companies are largest vaccine producer on the planet.
  • Indian pharma companies are largest manufacturers and exporters of generic medicines.
  • Indian pharma industry generates over $11 bn of trade surplus every year.
  • Indian pharma export to United States reached USD 16.28 B in FY20.

As indicated by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharma market turnover arrived at Rs 129,015 crore (US$18.12 billion) in 2018, becoming 9.4 percent year-on-year and exports income was US$17.28 billion in FY18 and US$19.14 billion in FY19.

The Government began to support the development of medication producing by Indian Pharma companies in the mid-1960s, and with the Patents Act in 1970.

Starting at 2002, more than 20,000 pharma companies in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, for the most part to the United States and to Russia. 250 of the biggest pharma companies control 70% of the Indian market. Multinationals addresses just 35% of the pharmaceutical market. As far as the worldwide pharmaceutical market, India right now is considered as pharmacy of the world.

Indian pharma companies carved a niche in both the Indian and world pharmaceutical markets with their aptitude in figuring out new cycles for assembling drugs at low costs which turned into the benefit for industry. Generic drugs, with 71% piece of the pie, structure the biggest section of the Pharmaceutical industry in India. This is set to grow as exports of generics to the United States rise, as branded drugs worth $55 bn has become off-patent during 2017-2019.

Top pharma companies in India are:

Rank Name Sales (Cr. INR) * % Growth
1 Sun Pharma 12194.9 7.9
2 Abbott 10244.8 6.9
3 Cipla 8787.4 13.6
4 Mankind 6499 11.7
5 Alkem 5976.6 7.1

 Top therapies in India are:

Rank Name Sales (Cr. INR) * % Growth
1 Cardiac 20645.4 13.8
2 Anti-Infectives 17500.3 -2.5
3 Gastro Intestinal 16769.2 11.7
4 Anti-Diabetic 15838.1 8.5
5 Nutraceuticals 13547.0 18

*- MAT April 21

Growth Drivers for Pharmaceutical industry:

  • Innovation and R&D
  • Medical tourism
  • Infrastructure development
  • Strong domestic demand
  • Strong drug manufacturing

Advantage of Indian Pharma industry:

  • Cost Efficiency: Low cost of production, R&D etc.
  • Economic Drivers: High economic growth along with increasing penetration of health insurance.
  • Increased Investment: The foreign direct investment inflows in the Indian Drugs and Pharmaceutical sector stood at USD 17.75 B between April 2000 and December 2020.


  • The Pharma industry in India is the third biggest on the planet as far as volume and 14th biggest as far as worth. It contributes 3.5% of the all-out medications traded around the world.
  • India, known as the Pharmacy of the World, is the biggest supplier of generic medications and perhaps the greatest provider of minimal expense vaccines worldwide.
  • India is the second biggest PPE Kits producer with a creation limit of 10 lakh+ PPE coveralls each day.
  • Pharma industry is one of the top ten attractive sectors for foreign investment in India.
  • The pharma exports from India reach more than 200 nations around the world, including highly regulated markets of the USA, West Europe, Japan, and Australia.
  • About 20% of the global exports in generic drugs are met by India.
  • The Indian pharma industry is the third-largest in the world by volume and 14th largest in terms of value. It contributes 3.5% of the total drugs and medicines exported globally.

Source: , , sale view (IQVIA) ,

Disclaimer: This page is a web base news aggregator. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill. No legal bounding on for any post


Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.